Jaye L. Thompson
Director Técnico/Científico/I+D en GREENWICH LIFESCIENCES, INC. .
Fortuna: 3 M $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Eric Rothe | M | 49 | 18 años | |
| Snehal Patel | M | 60 | 14 años | |
| David McWilliams | M | 80 | 15 años | |
| F. Daugherty | M | 73 | 5 años | |
| Kenneth Hallock | M | 75 | 5 años | |
| Christine T. Fischette | M | - | 3 años | |
| Fernando Martinez | M | - |
inVentiv Clinical Solutions LLC
| 16 años |
| Walter Ulrich | M | - |
Gulf Coast Regional Center of Innovation & Commercialization
| - |
| Joachim F. Wernicke | M | 76 | 11 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Joseph S. Podolski | M | 76 | 28 años | |
| Larry Dillaha | M | 60 | 1 años | |
| Jean L. Fourcroy | M | 93 | 9 años | |
| David Hung | M | 67 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 años |
| Patrick P. Fourteau | M | 77 | 2 años | |
| Gail Maderis | F | 66 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 6 años |
| Michael Wyllie | M | 73 | 7 años | |
| Donald Healey | M | 62 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 7 años |
| Kenny S. Frazier | M | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
| Sona Saira Ramasastry | F | 48 | 5 años | |
| Mark Lappe | M | 57 | 1 años | |
| Ronald D. Wiehle | M | 75 | 19 años | |
| Karthik Radhakrishnan | M | 53 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 años |
| Donald Tredway | M | - | - | |
| Michael Suesserman | M | 59 | 2 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 24 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Jaye L. Thompson
- Red Personal